Matrivax Research and Development
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
650 Albany St Rm 117, Boston, Massachuse...Phone Number
(617) 638-0350Website
www.matrivax.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Matrivax Research and Development
Matrivax Corporation is dedicated to developing life-saving vaccines aimed at addressing critical global health issues. Their key products include a next-generation pneumococcal vaccine candidate MVX01 designed to reduce the impact of pneumococcal disease, which causes over a million deaths annually. Additionally, they are working on a novel triple antigen vaccine candidate MVX02 targeting C. difficile, an urgent public health threat responsible for approximately half a million infections in the U.S. each year. Their intended clients include public health organizations and populations in need of effective vaccination solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Matrivax Research and Development your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Matrivax Research and Development launches new products
Click to see if Matrivax Research and Development had a recent Job posting/layoffs
Check out if Matrivax Research and Development is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Matrivax Research and Development, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Matrivax Research and Development has new funding data
Earning: See what the market has to say on Matrivax Research and Development recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Matrivax Research and Development
Check if Matrivax Research and Development has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Matrivax Research and Development
Compare insights from companies similar to Matrivax Research and Development, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Matrivax Research and Dev...
<$5M
11-50
Private
-
2007
N/A
Company Profile Activity
Activity Insights
Matrivax Research and Development is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Matrivax Research and Development is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Matrivax Research and Development.
Matrivax Research and Development Tech Stack
A closer look at the technologies used by Matrivax Research and Development
Matrivax Research and Development News & Media
Matrivax Appoints Dr. Enda Moran as Vice President of Process Development and CMC
Matrivax Research and Development Corporation has named Enda Moran, PhD, MBA, as vice president of process development and CMC. Dr. Moran will lead process development, chemistry, manufacturing and controls for Matrivax' preclinical- and clinical-stage products.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Matrivax Research and Development
Sign Up For FreeTo access detailed company insights
Matrivax Corporation is dedicated to developing life-saving vaccines aimed at addressing critical global health issues. Their key products include a next-generation pneumococcal vaccine candidate MVX01 designed to reduce the impact of pneumococcal disease, which causes over a million deaths annually. Additionally, they are working on a novel triple... Read More
